EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 163 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2023. The put-call ratio across all filers is 2.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $209,362 | -56.0% | 62,403 | 0.0% | 0.00% | -100.0% |
Q2 2023 | $475,511 | -57.7% | 62,403 | -44.0% | 0.00% | -50.0% |
Q1 2023 | $1,123,006 | -17.6% | 111,520 | -4.2% | 0.00% | 0.0% |
Q4 2022 | $1,363,149 | -44.0% | 116,409 | +2.3% | 0.00% | -50.0% |
Q3 2022 | $2,433,000 | -29.8% | 113,834 | -0.5% | 0.00% | -20.0% |
Q2 2022 | $3,468,000 | -28.0% | 114,418 | -0.8% | 0.01% | -16.7% |
Q1 2022 | $4,820,000 | -6.4% | 115,319 | +1.4% | 0.01% | 0.0% |
Q4 2021 | $5,151,000 | -12.1% | 113,741 | +1.2% | 0.01% | -25.0% |
Q3 2021 | $5,860,000 | -16.3% | 112,374 | +1.1% | 0.01% | -11.1% |
Q2 2021 | $7,001,000 | -25.3% | 111,138 | +9.3% | 0.01% | -35.7% |
Q1 2021 | $9,378,000 | +0.9% | 101,644 | -2.0% | 0.01% | -6.7% |
Q4 2020 | $9,291,000 | -16.1% | 103,692 | -2.2% | 0.02% | -28.6% |
Q3 2020 | $11,076,000 | -31.5% | 105,981 | -49.6% | 0.02% | +23.5% |
Q2 2020 | $16,174,000 | +181.0% | 210,126 | +100.4% | 0.02% | +21.4% |
Q1 2020 | $5,755,000 | +4.7% | 104,875 | +4.4% | 0.01% | +27.3% |
Q4 2019 | $5,498,000 | +52.3% | 100,437 | +42.4% | 0.01% | +37.5% |
Q3 2019 | $3,609,000 | +6.6% | 70,554 | +0.7% | 0.01% | 0.0% |
Q2 2019 | $3,385,000 | -53.7% | 70,054 | -51.6% | 0.01% | -46.7% |
Q1 2019 | $7,308,000 | -70.9% | 144,628 | -65.9% | 0.02% | -28.6% |
Q4 2018 | $25,134,000 | +32.1% | 423,960 | +46.6% | 0.02% | +5.0% |
Q3 2018 | $19,032,000 | +135.6% | 289,132 | +80.7% | 0.02% | +5.3% |
Q2 2018 | $8,077,000 | +43.6% | 159,975 | +49.7% | 0.02% | +46.2% |
Q1 2018 | $5,626,000 | +109.8% | 106,861 | +85.2% | 0.01% | +116.7% |
Q4 2017 | $2,681,000 | +10.5% | 57,691 | -3.9% | 0.01% | 0.0% |
Q3 2017 | $2,427,000 | +15.3% | 60,006 | -3.3% | 0.01% | +20.0% |
Q2 2017 | $2,105,000 | +48.9% | 62,082 | +27.5% | 0.01% | +25.0% |
Q1 2017 | $1,414,000 | +2.4% | 48,703 | +15.8% | 0.00% | 0.0% |
Q4 2016 | $1,381,000 | -0.4% | 42,067 | -4.3% | 0.00% | 0.0% |
Q3 2016 | $1,386,000 | +67.0% | 43,966 | +48.8% | 0.00% | +300.0% |
Q2 2016 | $830,000 | +501.4% | 29,546 | +678.1% | 0.00% | – |
Q1 2016 | $138,000 | -17.9% | 3,797 | -9.6% | 0.00% | -100.0% |
Q4 2015 | $168,000 | +40.0% | 4,200 | 0.0% | 0.00% | – |
Q3 2015 | $120,000 | -13.0% | 4,200 | 0.0% | 0.00% | – |
Q2 2015 | $138,000 | – | 4,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |